Forty-four patients with central nervous system metastases were treated with combination chemotherapy (adriamycin, VM 26 and CCNU). The best results were obtained in breast adenocarcinoma and small cell lung carcinoma with multiple, small cerebral metastases and without concomitant visceral involvement at other sites. The potential effectiveness of this regimen to prevent cerebral metastases is discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/030089168106700608 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!